Zishu Wang

Donafenib Versus Sorafenib in First-Line Treatment of Unresectable or Metastatic Hepatocellular Carcinoma: A Randomized, Open-Label, Parallel-Controlled Phase II-III Trial

Shukui Qin, Feng Bi, Shanzhi Gu et al. · Journal of Clinical Oncology · 2021 · 414 citations · Full text

Pharmacy, Oncology, Pharmacology +14

Apatinib as second-line or later therapy in patients with advanced hepatocellular carcinoma (AHELP): a multicentre, double-blind, randomised, placebo-controlled, phase 3 trial

Shukui Qin, Li Qiu, Shanzhi Gu et al. · ˜The œLancet. Gastroenterology & hepatology · 2021 · 254 citations

Medicine, Oncology, Pharmacotherapy +10

MiR-130a-3p regulates cell migration and invasion via inhibition of Smad4 in gemcitabine resistant hepatoma cells

Yang Liu, Yumei Li, Rui Wang et al. · Journal of Experimental & Clinical Cancer Research · 2016 · 90 citations · Full text

Life Sciences, Cell Biology, Oncology +17

Schisantherin A induces cell apoptosis through ROS/JNK signaling pathway in human gastric cancer cells

Zishu Wang, Kaikai Yu, Yudong Hu et al. · Biochemical Pharmacology · 2019 · 68 citations

Life Sciences, Cell Biology, Oncology +13

The RNA helicase DDX5 promotes viral infection via regulating N6-methyladenosine levels on the DHX58 and NFκB transcripts to dampen antiviral innate immunity

Jian Xu, Yunhong Cai, Zhenbang Ma et al. · PLoS Pathogens · 2021 · 68 citations · Full text

Life Sciences, Infectious Diseases, Molecular Biology +17